Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 18Breast Neoplasms 12Neoplasm Metastasis 3Neoplasms by Site 2Neoplasms 2Breast Diseases 2Sleep Wake Disorders 1Skin Diseases 1Salivary Gland Adenoma, Pleomorphic 1Osteoporosis 1Leiomyoma 1Hemorrhage 1Fatigue 1Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer 1Breast Neoplasms, Male 1Advanced Breast Cancer 1

Interventions

Zoledronic Acid 8Vitamin D 6Risedronic Acid 6Cholecalciferol 4Calcium Carbonate 4Alendronate 4Letrozole 3Denosumab 3Calcium 3Absorptiometry, Photon 3Calcium Gluconate 2Toremifene 1Spectrum Analysis 1Radiotherapy 1Progestins 1Ibandronic Acid 1Hormone Replacement Therapy 1Goserelin 1Gonadotropin-Releasing Hormone 1Geritol 1Estrogens 1Estrogen Replacement Therapy 1Estrogen Antagonists 1Estradiol 1Dietary Supplements 1Diet, Fat-Restricted 1Calcium Citrate 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Osteoporosis × Gonadotropin-Releasing Hormone × Clear all
NCT00329797 2017-11-29

Zoledronate in Preventing Osteoporosis and Bone Fractures in Patients With Locally Advanced Nonmetastatic Prostate Cancer Undergoing Radiation Therapy and Hormone Therapy

Radiation Therapy Oncology Group

Phase 3 Completed
109 enrolled 8 charts
Genitourinary

Osteoporosis, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡